SuffelStocks™ Day 20

By Brandon M. Suffel Founder Breakfast at Midnight April 29, 2020

Tesla breaks 800 and the CEO Elon Musks Twitter fingers can’t stop. Remdesivir by Gilead Sciences sends the stock soaring, however this upsets non-investors. Maybe they just missed their opportunity…

Twitter: @SuffelStocks
StockTwits: @SuffelBMS

Elon Musk can back it up

Russian Space Chief Calls Elon Musk a 'Pentagon Contractor' and ...

Tesla creator and CEO Elon Musk went to Twitter today to share his out-of-the-ordinary opinions. Many were pissed off by his comments, and others supported him. I’m staying out of it though!

Elon Musk unveiled his concerns for American freedom today at 2:14 AM, and some my argue his most loud spoken comment; “FREE AMERICA NOW” began to trend on Twitter into the afternoon. Obviously he sounds frustrated. I would be too. His plant in California is still closed, and his employees have been out of work, or even been laid off. New projects in America for Tesla and Musk continue to be a challenge.

$TSLA stock conquered the 800 mark today, and finished at $800.51 at the bell. Once Q1 earnings were released, shares astoundingly reached 875 at one point. As of now, shares have jumped $73.72 (+9.21%) in the after hours.

Dr. Fauci likes it

Widespread Testing for Coronavirus Coming in Next Week or Two: US ...

The wonder drug: Remdesivir, by Gilead Sciences, is receiving support from Dr. Anthony Fauci, of the United States.

CNBC – Dr. Anthony Fauci says Gilead’s remdesivir will set a new ‘standard of care’ for coronavirus treatment

It’s still unclear as to whether the drug is ready-to-go, but results from the study said the recovery time from infection from the coronavirus, has fallen from 15 days to 11.

Gilead and Acrus both jumped in the market, however many of those who don’t follow the stock market think it’s a total ploy to jack up the companies share prices. Some speculate the United States government is trying to make Gilead a total buy. While the state of China prohibits using the new wonder drug.

I personally don’t agree with the arguments that scientific breakthrough makes the stock a buy–at least right away. On Apr. 16, I covered the case study of remdesivir, and indicated; as more positive news is released regarding the remdesivir drug, obviously the stock prices of Gilead and Acrus would rise–and without a doubt.

SuffelStocks™ Day 12 — Breakfast at Midnight

$GILD stock jumped $4.47 (+5.68%) in market hours. In after hours shares jumped another $1.99 (+2.39%).

$RCUS stock jumped $1.21 (+4.50%) in market hours. A small loss of (-0.27%) in the after hours hasn’t fazed investors for tomorrow.

SuffelStocks™ Day 19

By Brandon M. Suffel Founder Breakfast at Midnight April 28, 2020

Starbucks and the earnings report that flipped the stock. The pharmacy stock I like. And, should we be focusing on stocks, and their losses, or the economy? That is, should we blame the stock market, or blame the economy for our misfortune?

Twitter: @SuffelStocks Stocktwits: @SuffelBMS


Starbucks giving out free drinks during 'Pop-up' happy hours

What’s goin on with Starbucks? There seems to be an issue…

Since Starbucks almost three point loss on Apr. 3, it’s recovered slowly but surely, but evidently, the fearful quarter two earnings report was just around the corner.

Of course, a majority of Starbucks locations are closed, nationwide, and nearly worldwide, besides the “areas” least affected by the coronavirus pandemic. That still doesn’t justify the plausible consequences of a “closed” economy over the last month-or so.

I’m not interested in the earnings, I’m interested in the guidance.

And unfortunately, I’m distraught with the results. The guidance from Starbucks was sullen. To say at the least. Is it necessary to complain? The economy can barely sustain easing restrictions of social distancing. Even the movement opening salons, bars, and restaurants again is a challenge. Starbucks falls into this category as a mindful sacrifice. Sure, some Starbucks locations have opened their drive-thru for customers, but how does that attain to a normal day of consumer traffic? It doesn’t. If you believe in the 25% – 35% of loss in business in the Chinese state, my compassion, and empathy, goes to those who still stick with Starbucks. Remember, it’s not your fault, and it’s not the stocks fault either.

$SBUX in trading hours filled trades from bullish investors as the share price continued to patiently uptick. After a positive close at $78.69, shares suddenly fell in the after hours, when the earnings report and guidance unleashed. The share price would soon come tumbling down (-1.16%). $SBUX remains volatile in the after hours.

I still believe Starbucks is great for portfolios. $SBUX stock teaches new-and current-investors the importance of compounding interest, having faith, and how the market can function in good and bad times.

I like Rite Aid

RITE AID | LinkedIn

I woke up Mar 16. early, with good intentions, and a hunger for market knowledge. Then I thought of an idea for trading: I’m going to invest in a safe play, one I know I’ll make my money back if my risky play backfires. And little did I know then, my risky play would make me richer than I was the day before, and so forth.

I chose Rite Aid. It wasn’t a radical choice. At the time, markets were swinging unbelievably negative, and it seemed the market couldn’t go any higher; but lower. So, Rite Aid at $10.10 a share – a steal – became a new hit like the other pharmacy crew ($WBA and $CVS). The big three would soon work with 45, and steal the market.

Since then, I still follow Rite Aid, CVS, and Walgreens, but today, Rite Aid just made sense.

$RAD shares made a sharp gain of $0.74/share (+4.90%). And in the after hours, shares continued the momentum.

Is it the Stock market? Is it the Economy?

Should we blame the Stock market or the economy for our misfortune today? An awfully probing question, if you ask me. I recently fell upon an article that may address those concerns… and here’s how I interpreted it:

Joshua M. Brown, the author of “You can’t invest in GDP,” immediately brings up an important point: Although stocks have recovered from their losses since Mar. 23 low; businesses have not.

Soon, we come across a letter, from a colleague of Josh’s, Ben Carlson, who makes fair judgment: When GDP declined 5% during the 2007-2009 financial crisis, stocks accordingly fell 50%. The financial crisis was a financial crisis. Whereas today, we’re in the midst of a natural disaster. In that case, the economy tends to do more damage on the lives of civilians compared to your stocks, Roth IRA’s, and 401k: A driven point investors and ordinary market analysts fathom.

Who are the winners, or those constantly bailed out in all of this? Josh addresses this eerie question with honesty. I interpreted it as the big corporations today continuously experience less regulations, and receive substantial aid like extravagant subsidies from the government; compared to small businesses who struggle to stay open. Small businesses aren’t financially capable to withstand a “closed-off” economy much longer.

I find it intriguing stock prices are merely opinions. They are generated numbers. Physically, stocks don’t exist–unless otherwise on written documents.

Joshua M. Brown captures this topic brilliantly, and analyzing this read taught me the value in stocks today, compared to yesterday’s prices, and tomorrow’s.

You can’t invest in GDP

SuffelStocks™ Day 18

By Brandon M. Suffel Founder Breakfast at Midnight April 27, 2020

Apple to start using their own chips in 2021. Facebook and Zoom go head-to-head. Two Pot stocks greener on a Monday!

Twitter: @SuffelStocks. Stocktwits: @SuffelBMS

Apple to use its own processors in 2021

Currently, Apple Macs use a core i5 processor. As of just recently, according to Bloomberg Technology, Apple plans to switch from using Intel i5 processors, and soon install Apple processors in future Mac products.

Next year, Apple plans to use one of its own chips in a new Mac product. Apple, and their agenda: Installing their own chips in their products, ensures more Apple.

$AAPL stock in the past month has smoothly recovered from sheer losses from sudden economic downturn. Today, shares were extremely volatile, after grabbing the news of technological independence. $AAPL stock reached $283.17 at the close, making a kind gain of (0.07%) just before trading hours ended.

Intel Corporation $INTC on the other hand, received the news without a chip on their shoulder. $INTC in trading hours started at a high of $59.62, until just before noon, shares fell to $58.42–warning investors of a possible sudden selloff. However, shares gradually recovered after lunch hours. And closed at $59.47.

The clash of video chat Titans

Facebook won’t go down without a fight. Just when the technology and social media industries want to bring Facebook down, they seem to always break-through. Even when the odds are against them.

Facebook recently introduced a new feature for users. A feature some may argue is awfully close to a Zoom video call. Through Facebook messenger, you now have the ability to video call with whomever you choose, and with however many you choose.

This feature can be accessed on the individual Facebook messenger application. And it sounds like Facebook’s stolen the casual group video chat sessions from Zoom.

Whereas Zoom focuses on video conferences. Also, Zoom is designed to be compatible as a classroom setting, compared to a Facebook video call setting.

Facebook serves over 2.37 billion active users. I’m sorry Zoom, but your mere 200 million users barely surpass Facebook, and the Facebook domination of the social network.

$FB stock today suffered sudden losses in market hours. Shares were barely able to keep up with the volatile selling and buying volume. By the final hour benchmark, shares made a preemptive fight to overcome a challenging Monday. Unfortunately shares fell even lower, to a final $187.50.

$ZM came to the fight prepared. $ZM gains of $5.80 (+3.65%), inches them closer to a $FB share price. $ZM stock in the after hours $164.20, indicates the fight will continue on tomorrow.

These guys

Canopy Growth Corporation and Tilray, Inc. both have had some tough recent months. Today however, they both shared unwarranted euphoria, and they seem to be richer than the day before.

$CGC shares in the past year have lost, and they’ve lost big. From almost $50 a share a year ago, shares currently rest at $17.53. Investors who though $CGC was the pot stock to go with, are now faced with a 66.42% share value loss. As for today, $CGC shares made a marginal gain of (+12.44%). Maybe a nudge to get them going once more.

$TLRY jumped on the same train as Canopy Growth in trading hours, and after the bell, ended up with a gain of (+4.09%). Also another nudge to possibly get the pot stocks moving bullish once again.